Literature DB >> 19621348

Erythropoiesis: model systems, molecular regulators, and developmental programs.

Asterios S Tsiftsoglou1, Ioannis S Vizirianakis, John Strouboulis.   

Abstract

Human erythropoiesis is a complex multistep developmental process that begins at the level of pluripotent hematopoietic stem cells (HSCs) at bone marrow microenvironment (HSCs niche) and terminates with the production of erythrocytes (RBCs). This review covers the basic and contemporary aspects of erythropoiesis. These include the: (a) cell-lineage restricted pathways of differentiation originated from HSCs and going downward toward the blood cell development; (b) model systems employed to study erythropoiesis in culture (erythroleukemia cell lines and embryonic stem cells) and in vivo (knockout animals: avian, mice, zebrafish, and xenopus); (c) key regulators of erythropoiesis (iron, hypoxia, stress, and growth factors); (d) signaling pathways operating at hematopoietic stem cell niche for homeostatic regulation of self renewal (SCF/c-kit receptor, Wnt, Notch, and Hox) and for erythroid differentiation (HIF and EpoR). Furthermore, this review presents the mechanisms through which transcriptional factors (GATA-1, FOG-1, TAL-1/SCL/MO2/Ldb1/E2A, EKLF, Gfi-1b, and BCL11A) and miRNAs regulate gene pattern expression during erythroid differentiation. New insights regarding the transcriptional regulation of alpha- and beta-globin gene clusters were also presented. Emphasis was also given on (i) the developmental program of erythropoiesis, which consists of commitment to terminal erythroid maturation and hemoglobin production, (two closely coordinated events of erythropoieis) and (ii) the capacity of human embryonic and umbilical cord blood (UCB) stem cells to differentiate and produce RBCs in culture with highly selective media. These most recent developments will eventually permit customized red blood cell production needed for transfusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621348     DOI: 10.1002/iub.226

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  83 in total

1.  5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation.

Authors:  Hee-Don Chae; Man-Ryul Lee; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

2.  A core erythroid transcriptional network is repressed by a master regulator of myelo-lymphoid differentiation.

Authors:  Sandeep N Wontakal; Xingyi Guo; Cameron Smith; Thomas MacCarthy; Emery H Bresnick; Aviv Bergman; Michael P Snyder; Sherman M Weissman; Deyou Zheng; Arthur I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-22       Impact factor: 11.205

3.  GATA-1 utilizes Ikaros and polycomb repressive complex 2 to suppress Hes1 and to promote erythropoiesis.

Authors:  Julie Ross; Lionel Mavoungou; Emery H Bresnick; Eric Milot
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

Review 4.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

Review 5.  Role of helix-loop-helix proteins during differentiation of erythroid cells.

Authors:  Archana Anantharaman; I-Ju Lin; Joeva Barrow; Shermi Y Liang; Jude Masannat; John Strouboulis; Suming Huang; Jörg Bungert
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

6.  Corepressor Rcor1 is essential for murine erythropoiesis.

Authors:  Huilan Yao; Devorah C Goldman; Tamilla Nechiporuk; Sunita Kawane; Shannon K McWeeney; Jeffrey W Tyner; Guang Fan; Marc A Kerenyi; Stuart H Orkin; William H Fleming; Gail Mandel
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

Review 7.  New strategies to target iron metabolism for the treatment of beta thalassemia.

Authors:  Paraskevi Rea Oikonomidou; Carla Casu; Stefano Rivella
Journal:  Ann N Y Acad Sci       Date:  2016-02-25       Impact factor: 5.691

8.  Transcriptome dynamics during human erythroid differentiation and development.

Authors:  Yadong Yang; Hai Wang; Kai-Hsin Chang; Hongzhu Qu; Zhaojun Zhang; Qian Xiong; Heyuan Qi; Peng Cui; Qiang Lin; Xiuyan Ruan; Yaran Yang; Yajuan Li; Chang Shu; Quanzhen Li; Edward K Wakeland; Jiangwei Yan; Songnian Hu; Xiangdong Fang
Journal:  Genomics       Date:  2013-10-08       Impact factor: 5.736

9.  MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathway.

Authors:  Chutima Kumkhaek; Wulin Aerbajinai; Wenli Liu; Jianqiong Zhu; Naoya Uchida; Roger Kurlander; Matthew M Hsieh; John F Tisdale; Griffin P Rodgers
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

10.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.